Orthopedic Biomaterials Market Research Report- Forecast till 2027

Orthopedic Biomaterial Market: Information by Product (Reconstructive Joint Replacement, SpinalImplants, Dental Implants,Trauma, Orthobiologics), Material Class (Metal andNon-Metal), Application (Joint Replacement, Fracture Fixation, Tissue Fixation, Implant Surgery,Visco Supplementation), End User (Hospitals & Clinics, Ambulatory Surgical Centers), and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Forecast till 2027

ID: MRFR/HC/0101-CR | August 2021 | Region: Global | 240 Pages         

Orthopedic Biomaterial Market

Orthopedic biomaterials market is expected to grow at a CAGR of 10.5% to reach USD 40,519.52 million during forecasted period 2020 to 2027.

Segmentation

By Product Reconstructive Joint Replacement SpinalImplants Dental Implants Trauma Orthobiologics
By Material Class Metal Non-Metal
By Application Joint Replacement Fracture Fixation Tissue Fixation Implant Surgery Visco Supplementation
By End User Hospitals & Clinics Ambulatory Surgical Centers

Key Players

  • Stryker (US)
  • CoorsTek Inc. (US)
  • Zimmer Biomet Holdings Inc. (US)
  • Institut Straumann AG (Switzerland)
  • Kyocera Corporation (Japan)
  • Smith & Nephew plc (UK)
  • 3M (US)
  • Nobel Biocare Services AG(Switzerland)
  • Medtronicplc (Ireland)
  • DePuy Synthes (US)

Drivers

  • Increasing older population leading to an increase in the patient population
  • Growing demand for next-generation orthopedic biomaterials
Speak to Analyst Request a Free Sample

Orthopedic Biomaterial Market Forecast


The orthopedic biomaterials market is expected to register a CAGR of 10.5% during the assessment period of 2020 to 2027, to reach USD 40,519.52 million by 2027.


Market Overview:


Orthopedic biomaterials are implanted in the human body as constituents. These devices are designed to perform certain biological functions by substituting or repairing different tissues such as bone, cartilage, or ligaments and tendons and even guiding bone repair when necessary.


The growth of the orthopedic biomaterials market is driven by factors such as the growing demand for next-generation orthopedic biomaterials and the increasing prevalence of orthopedic diseases. In addition, the increasing prevalence of chronic diseases creates a lucrative opportunity for the market. However, lack of reimbursement and an ambiguous regulatory framework is likely to restrain the market growth.


COVID-19 Analysis:


The pandemic is likely to have devastating effects on the global economy, more intense than the global financial crisis during 2008-2009. It is affecting the demand and supply chain, which will severely hurt global trade. The top players in the market are expected to continue to fulfill the current demand for orthopedic biomaterials, including reconstructive joint replacements and spinal implants. Furthermore, various governments across the world are encouraging the key players to improve the current manufacturing facilities. However, with the decline in elective surgical procedures, the orthopedic biomaterials market is expected to witness a slump in 2020.


Market Dynamics:


Drivers


  • Increasing older population leading to an increase in the patient population


Geriatric individuals are more susceptible to orthopedic diseases. Thus, the growing geriatric population is likely to increase the demand for orthopedic biomaterials. According to the Office for National Statistics, in 2017, ~18% and 2.4% of the total UK population was aged over 65 years and 85 years, respectively. With the high incidence of joint replacement procedures, over 1 million hip and total knee replacement procedures are performed each year in the US. This huge number of joint and knee replacements is increasing the demand for orthopedic biomaterial. Therefore, the growing elderly population is anticipated to boost the growth of the global orthopedic biomaterials market over the assessment period.

Growing demand for next-generation orthopedic biomaterials


Restraints


  • Lack of reimbursements


Limited reimbursement coverage options are present for these products. The reimbursement for orthopedic biomaterials is also declining in various countries, which has impeded market growth. This lack of reimbursements has put pressure on manufacturers to lower the prices for these materials. All these factors have restricted the growth of the market.


Opportunities


  • Technological advancement in the medical implants market


Nowadays, consumers are becoming more conscious and aware of the issues related to health. Thus, companies are focusing more on research & development to introduce better technology and treatment, which gives them an edge over their competitors. Companies are looking forward to introducing innovative technologies. Currently, several devices are present in the market for various medical conditions. Players focus on the development of technologically advanced products. For instance, in September 2019, Zimmer Biomet Holdings, Inc., a US-based healthcare solutions provider, announced FDA 510(k) clearance for the Persona Revision Knee System for revision knee replacement procedures. It offers components designed to match a patient's anatomy for a personalized fit.


Orthopedic Biomaterials Market Share (%), by Product, 2019
Global Orthopedic Biomaterials Market Share (%), by Product, 2019
Source: MRFR Analysis


Value Chain Analysis


The global orthopedic biomaterials market is growing steadily due to the rising incidence of orthopedic injury and growing demand for next-generation orthopedic biomaterial. So,with the rising use of orthopedic biomaterial, many players are showing keen interest in launching new products. The value chain analysis of the orthopedic biomaterials market comprises four major components: the software development process and designing, followed by R&D and designing, manufacturing, distribution, marketing,and sales with post-selling services.


Segment Overview:


By Product



  • Reconstructive Joint Replacements:


Reconstructive joint replacement is a medical procedure that includes the replacement of the damaged joint. It includes minor repair to total joint replacement, and offers pain relief as well as permanent solutions to joint disorders. Reconstructive joint replacements include various types of implants, such as knee replacement implants, hip replacement implants, and others. According to the American Academy of Orthopedic Surgeons (AAOS), around 1.6 million hip and knee surgeries and 966,000 knee replacements were performed in the US in 2017.


The market growth of this segment is attributed to the increasing geriatric population and rising cases of orthopedic surgery. Moreover, there has been a strong focus on improving healthcare services globally, which further boosts the market's growth.



  • Spinal Implants:


A spinal implant is a type of medical device used in the management of spine disorders. Spinal implants consist of polyetheretherketone (PEEK) and titanium alloys. Cobalt chromium alloys are used in disc replacements type of spinal implants. As per the North American Spine Society, around 1.4 million spinal procedures were performed each year in the US. The largest number of procedures were performed in cervical repair, with over 350,000 total procedures.



  • Dental Implants:


Dental implants are a type of surgical component that edges with the jaw's bone to support dental prostheses like crowns, dentures, and facial prostheses. Moreover, the modern dental implant is a biological process also known as osseointegration, in which titanium material is used to form a close bond to the bone. Dental implants have two types such as root-form dental implants and plate-form dental implants.



  • Trauma:


Trauma is a critical injury to the bones, joints, ligaments, muscles, and soft tissue caused by accident and fall. As per the World Health Organization, prevalence of trauma orthopedic injury is around 63.6%.



  • Orthobiologics:


Orthobiologics are biological substances used to provide relief in musculoskeletal injuries.Orthobiologics are various types such as viscosupplementation, demineralized bone matrix, synthetic bone substitutes, bone morphogenetic proteins, and allograft.



  • Others:


This segment includes orthopedic biomaterials such as bio-resorbable tissue fixation, and osteosynthesis among others.


By Material Class



  • Metal


In load-bearing systems such as hip and knee prostheses and to fix internal and external bone fractures, metallic biomaterials haveprincipal applications. It is important to know the physical and chemical properties and interaction with the human body's host tissue of the various metallic materials used in orthopedic surgery.


  • Non-Metal


With the magnum PI's polyetheretherketone (PEEK) implant material systems, surgeons who choose not to use metal anchors may incorporate alternatives. The system can be seen in several shoulder-related surgical operations and Achilles tendon replacements, among many other indications. Together with cortical bone lock, knotless fixation, and a simple technique, an implant makes the procedure quick, effective, and secure. The implant is put in an easy-to-use implanted handle.


By Application



  • Joint Replacement


The joint replacement procedure eliminates and replaces damaged or diseased joint parts with new and artificial parts. The growth during the forecast period in the knee segment has been led by a rise in the number of knee replacement procedures, robotic-assisted replacement procedures, and the introduction of products such as the ATTUNE Revision Knee System, the Persona Partial Knee System, and JOURNEY II XR Total Knee by key manufacturers.


  • Fracture Fixation


The rising geriatric population, rapid adoption of new technologies, rising prevalence of osteoporosis, and increasing injuries are the main factors for the growth of the orthopedic fracture fixation segment. Changes in the lifestyle, such as lack of exercise, early burnout, and increased obesity amongst people are resulting in the weakening of bone fractures, which drive the growth of theorthopedicbiomaterials market.



  • Tissue Fixation


Sportspersons recovering from athletic injuries isa significant factor supporting the market growth of soft tissue fixation. The incidence of sports accidents, which is projected to fuel the market growth, will also increase with a growing number of children and teenagers taking part in sports activities.



  • Implant Surgery


Orthopedic implants are used to repair or sustain a broken or deformed bone or joint. These implants are designed to cure posture issues, regain natural skeletal functions, and remove deformities. An orthopedic implant is to replace older prosthetics. The demand for orthopedic implant products has increased due to a rise in the geriatric population, raising the risk of osteoporosis, osteoarthritis, and other musculoskeletal disorders.



  • Viscosupplementation


Viscosupplementation is a minimally invasive technique in which an injection of hyaluronic acid (an active compound in synovial fluid) is commonly used. The bulk of the orthopedic operations are performed in the leg. There are 1 to 3 injection procedures with 3-injection treatments showing better pain relief than a 1-injection regimen.


By End User



  • Hospitals & Clinics


There has been a significant increase in the number of hospital admissions and patient visits for orthopedic surgeries in the majority of the countries. In 2017, the number of orthopedic surgery procedures performed globally totaled around 22.3 million. The hospitals & clinics segment dominated the global orthopedicbiomaterials market in 2019 in terms of revenue.



  • Ambulatory Surgical Centers


Ambulatory Surgery Centersor ASCs, are modern healthcare facilities where surgeries do not require hospital admission and provide same-day surgical care, including diagnostic and preventive procedures. The orthopedic biomaterial provided by ASCs is anticipated to increase the number of patients opting for orthopedic injury during the forecast period.



  • Others


The others segment includes research& academics, nursing homes, etc. The growth of the segment is attributed to the growing use of orthopedic biomaterial in various orthopedic diseases.


Orthopedic Biomaterials Market Share, by Region, 2019 (%)
Global Orthopedic Biomaterials Market Share, by Region, 2019 (%)
Source: MRFR Analysis


Regional Analysis


Americas:


The Americas dominated the orthopedicbiomaterials market in 2019 and is likely to continue during the assessment period as well. This can be attributed to the high prevalence of orthopedic diseases, product launches, and technological advancement in this region. The high demand for orthopedic biomaterials and the adequate availability of skilled professionals in the region are expected to fuel the regional market growth. The growing elderly population is also resulting in the growth of the orthopedicbiomaterials market in the Americas. As per the Administration for Community Living, in the Americas, over the last ten years, the population aged 65 and over grew from 37.2 million in 2006 to 49.2 million in 2016.


Europe:


Europe held the second-largest position in the orthopedic biomaterials market in 2019 and is anticipated to witness significant growth over the forecast period due to a higher number of patients and the availability of products in the region. In 2017, Switzerland, Finland, Luxembourg, Germany, Austria, and Belgium were among the countries with the highest number of hip and knee replacements in the region. The OECD averages are 182 per 100,000 population for hip replacements and 135 per 100,000 for knee replacements. On average, hip replacement rates increased by 30% between 2007 and 2017, and knee replacement rates increased by 40% in the same period. This increase in patients undergoing knee and replacement is anticipated to boost the regional market's growth.


Asia-Pacific:


The Asia-Pacific is anticipated to register the highest growth rate duringthe forecast period. According to the United Nations, across Asia, the number of people aged 65 and above is expected to grow dramatically over the next 50 years. For the region, the population in this age group will increase by 31.4%, from 207 million in 2000 to 857 million in 2050. A large number of adults residing in the region are expected to suffer from various orthopedic disorders. This is expected to drive the growth of the regional orthopedicbiomaterials market during the study period.


Middle East & Africa:


The orthopedic biomaterials market in the Middle East & Africa has been growing steadily in recent years. The key factors propelling the growth of the regional market are the increasing the prevalence of orthopedics disorders and funding by private players and government bodies.


Competitive Landscape


The global orthopedic biomaterials market is characterized by the presence of many global, regional, and local vendors catering to the demand created by a large patient pool in need of diagnostic and surgical services. The availability of innovative products is increasing the lucrativeness of the global orthopedic biomaterials market. The key players have adopted the strategy of signing contracts and agreements to expand their global presence and optimize operational costs.


The market is highly competitive, with players competing and partnering to gain a substantial market share. The global orthopedic biomaterials market is moderately consolidated with rising competition, product launches, rising collaborative partnerships, and other strategic decisions to achieve operational efficiency. The vendors compete based on cost, quality, timely availability, and reliability of products offered. It is decisive for the players operating in the orthopedic biomaterials market to provide cost-efficient products to survive and succeed in an increasingly competitive and growing market environment.


List of Key Companies Covered in this Report:



  1. Stryker (US)

  2. CoorsTek Inc. (US)

  3. Zimmer Biomet Holdings Inc. (US)

  4. Institut Straumann AG (Switzerland)

  5. Kyocera Corporation (Japan)

  6. Smith & Nephew plc (UK)

  7. 3M (US)

  8. Nobel Biocare Services AG(Switzerland)

  9. Medtronicplc (Ireland)

  10. DePuy Synthes (US)


Recent Developments



  • In September 2020, Smith&Nephew (UK) received approval from the National Medical Products Administration (NMPA), China, to introduce its REDAPT System for Revision Total Hip Arthroplasty (RTHA).

  • In March 2020, DePuy Synthes (US) received the European CE mark for its new BI-MENTUM Dual Mobility System for use in patients with a higher risk of dislocation. The system is designed to reduce the risk of dislocation

  • In January 2020, Nobel Biocare (Switzerland)unveiled Nexus Universal, a universal adhesive resin cement that allows medical personnel to cut their steps by half while delivering up to 2 times higher bond strength on any substrate


Report Overview:


The report contains:



  • Global orthopedic biomaterials market size and estimation from past years to forecast period (2017-2027).

  • The major market segments and their share, globally as well as regionally.

  • The market drivers, restraints, and opportunities.

  • Competitive landscape of the global orthopedic biomaterial market

  • Key market players profiling along with SWOT analysis


Scope of the Report & Segmentation


Orthopedic Biomaterials Market, by Product



  • Reconstructive Joint Replacements

    • Knee Replacement Implants

    • Hip Replacement Implants

    • Extremities



  • Spinal Implants

    • Spinal Fusion Implants

    • Vertebral Compression Fracture (VCF) Devices

    • Motion Preservation Devices/Non-Fusion Devices  



  • Dental Implants

    • Root-Form Dental Implants

    • Plate-Form Dental Implants



  • Trauma

  • Orthobiologics

    • Viscosupplementation

    • Demineralized Bone Matrix (DBM)

    • Synthetic Bone Substitutes

    • Bone Morphogenetic Protein (BMP)

    • Allograft

    • Others



  • Others


Orthopedic Biomaterials Market, by Material Class



  • Metal

    • Stainless Steel

    • Titanium Alloy

    • Cobalt Alloy

    • Others



  • Non-Metal

    • Ceramic

      • Alumina

      • Calcium Phosphate

      • Zirconium Dioxide

      • Carbon

      • Others



    • Polymeric

      • Polymethylmethacrylate (PMMA)

      • Polyethylene

      • Silicone

      • Polyester

      • Others






Orthopedic Biomaterials Market, by Application



  • Joint Replacement

    • Hip Replacement

    • Knee Replacement

    • Shoulder and Elbow Replacement

    • Others



  • Fracture Fixation

  • Tissue Fixation

  • Implant Surgery

  • Viscosupplementation

  • Other


Orthopedic Biomaterials Market, by End User



  • Hospitals & Clinics

  • Ambulatory Surgical Centers

  • Others


Global Orthopedic Biomaterials Market, by Region



  • Americas

    • North America

      • US

      • Canada

      • Latin America





  • Europe

    • Western Europe

      • Germany

      • France

      • UK

      • Italy

      • Spain

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Middle East & Africa

    • Middle East

    • Africa





Report Scope:

Report Attribute/Metric Details
  Market Size   USD 40,519.52 Million
  CAGR   10.5% (2020-2027)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2017-2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product, Material Class,Application, and End Use
  Geographies Covered   Americas, Europe, Asia-Pacific, Middle East & Africa
  Key Vendors   Stryker (US), CoorsTek Inc (US), Zimmer Biomet Holdings Inc (US), Institut Straumann AG (Switzerland), Kyocera Corporation (Japan), Smith& Nephew plc (UK),3M (US), NobelBiocare Services AG(Switzerland), Medtronic plc (Ireland), DePuy Synthes (US).
  Key Market Opportunities   Technological advancement in the medical implant market, Adoption of growth strategies by key players.
  Key Market Drivers   Growing demand for next-generation orthopedic biomaterials, increasing older population leading to increase in patient population, rising prevalence of orthopedic diseases.


Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

Orthopedic Biomaterial Market is expected to grow at 10.5% CAGR By 2027.

DePuy Synthes, Kyocera Corporation, Stryker, 3M ESPE, Materion Corporation, CERADYNE, Straumann, CoorsTek Inc., Nobel Biocare Services AG, and Morgan Advanced Materials are prominent players of the global orthopedic biomaterial market.

The Americas can dominate the Orthopedic Biomaterial Market due to large demand for implants and the huge number of surgical procedures.

The APAC can grow at a robust rate due to prevalence of various chronic diseases and the large elderly populace in Chin

The large geriatric populace and the massive demand for implants are major drivers of the Orthopedic Biomaterial Market.